0HHO

Argan Inc.

Common Stock · USD · NYSE

AGXT212

Price

$678.54

-0.76%

Cap

$808.33B

Earnings

30d Trend

+7.4%

0HHO
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

80% annualised over 90 days

Next earnings:2026-06-03

BRAIN47 SIGNAL

0
STRONG
Risk Level73
Quality72
Momentum88
Technical51
Fundamentals35

Raw weighted: 57×Macro 0.99 (1%)=56

RISK

73/100
90d Volatility
80.1%High
ATR %
5.3%High daily moves
Max Drawdown (1Y)
-25.0%Normal

QUALITY

72/100
ROE (avg)
29.8%Excellent
Piotroski F-Score
6/9Average
Margin Stability
CV 15.2%Volatile
Accruals
-23.3%Cash earnings

MOMENTUM

88/100
12-1M Momentum
+221.6%Strong uptrend
6-1M Momentum
+64.3%Positive
1M Return
+7.5%Strong recent gains

TECHNICAL

51/100
RSI (14)
54.8Neutral
Price vs SMA200
+71.0%Bullish trend
MACD
-7.58Bearish momentum
Bollinger Band
44%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.125Noisy/choppy

FUNDAMENTALS

35/100
EV/EBIT
60.0Expensive
P/FCF
20.5Fair
P/S
8.9Expensive
Shareholder Yield
0.4%Low

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months50
3-12 months85
1-5+ years57

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Argan Inc. at 56/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 88/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+7.5%

3 MONTHS

+50.2%

12 MONTHS

+229.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (88) and Quality (72) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 80%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 56/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.